Published in Chemotherapy on April 18, 2001
Hospital epidemiology and infection control in acute-care settings. Clin Microbiol Rev (2011) 2.22
Synergistic interaction between Candida albicans and commensal oral streptococci in a novel in vitro mucosal model. Infect Immun (2011) 1.20
The Pathophysiology and Treatment of Candida Sepsis. Curr Infect Dis Rep (2002) 1.00
Need for a comprehensive medical approach to the neuro-immuno-gastroenterology of irritable bowel syndrome. World J Gastroenterol (2011) 0.77
Helicobacter is preserved in yeast vacuoles! Does Koch's postulates confirm it? World J Gastroenterol (2017) 0.75
Resistance to ticarcillin-potassium clavulanate among clinical isolates of the family Enterobacteriaceae: role of PSE-1 beta-lactamase and high levels of TEM-1 and SHV-1 and problems with false susceptibility in disk diffusion tests. Antimicrob Agents Chemother (1988) 3.92
Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy. Bone Marrow Transplant (2007) 2.74
Guidelines for the diagnosis of tick-borne bacterial diseases in Europe. Clin Microbiol Infect (2004) 2.59
A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancer. Br J Cancer (2006) 2.57
Resistance to activated protein C and low levels of free protein S in Greek patients with inflammatory bowel disease. Am J Gastroenterol (2000) 2.33
Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection. Antimicrob Agents Chemother (2006) 2.31
Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program. Med Mycol (2005) 2.29
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut (2006) 1.87
Resistance to itraconazole in Aspergillus nidulans and Aspergillus fumigatus is conferred by extra copies of the A. nidulans P-450 14alpha-demethylase gene, pdmA. J Antimicrob Chemother (2001) 1.82
Detection and identification of Leishmania DNA within naturally infected sand flies by seminested PCR on minicircle kinetoplastic DNA. Appl Environ Microbiol (2000) 1.65
Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer: Retrospective analysis of 245 episodes. Arch Intern Med (2000) 1.62
Identification to the species level and differentiation between strains of Aspergillus clinical isolates by automated repetitive-sequence-based PCR. J Clin Microbiol (2004) 1.59
Instruments for quality of life assessment in patients with inflammatory bowel disease. Dig Liver Dis (2000) 1.55
Protothecosis in patients with cancer: case series and literature review. Clin Microbiol Infect (2003) 1.50
High-dose caspofungin combination antifungal therapy in patients with hematologic malignancies and hematopoietic stem cell transplantation. Bone Marrow Transplant (2007) 1.48
The impact of prior invasive mold infections in leukemia patients who undergo allo-SCT in the era of triazole-based secondary prophylaxis. Bone Marrow Transplant (2012) 1.47
Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature. Clin Infect Dis (1996) 1.43
Utility of galactomannan enzyme immunoassay and (1,3) beta-D-glucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients. J Clin Microbiol (2008) 1.39
Clinical presentation of zygomycosis. Clin Microbiol Infect (2009) 1.38
The epidemiology of onychomycoses in Crete, Greece, between 1992 and 2001. J Eur Acad Dermatol Venereol (2006) 1.38
Evidence for an efflux pump in multidrug-resistant Campylobacter jejuni. Antimicrob Agents Chemother (1995) 1.38
Hyperbaric oxygen as an adjunctive treatment for zygomycosis. Clin Microbiol Infect (2005) 1.32
Isolation and identification of a rickettsial strain related to Rickettsia massiliae in Greek ticks. Am J Trop Med Hyg (1994) 1.30
Immunocompromised hosts: immunopharmacology of modern antifungals. Clin Infect Dis (2008) 1.29
Inhaled colistin as adjunctive therapy to intravenous colistin for the treatment of microbiologically documented ventilator-associated pneumonia: a comparative cohort study. Clin Microbiol Infect (2009) 1.29
Use of the Diversi Lab System for species and strain differentiation of Fusarium species isolates. J Clin Microbiol (2005) 1.28
In vitro susceptibility of Coxiella burnetii to trovafloxacin in comparison with susceptibilities to pefloxacin, ciprofloxacin, ofloxacin, doxycycline, and clarithromycin. Antimicrob Agents Chemother (1998) 1.28
Crohn's disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohort. Gut (2005) 1.26
Role of catheter colonization and infrequent hematogenous seeding in catheter-related infections. Eur J Clin Microbiol Infect Dis (1995) 1.24
Infection and immunity in chronic lymphocytic leukemia. Mayo Clin Proc (2000) 1.23
Morganella morganii infections in a general tertiary hospital. Infection (2006) 1.21
Newer macrolides as empiric treatment for acute Q fever infection. Antimicrob Agents Chemother (2001) 1.20
Prevalence study of hospital-acquired infections in 14 Greek hospitals: planning from the local to the national surveillance level. J Hosp Infect (2002) 1.20
Voriconazole-associated zygomycosis: a significant consequence of evolving antifungal prophylaxis and immunosuppression practices? Clin Microbiol Infect (2009) 1.19
Comparison of the efficacy of polyenes and triazoles against hematogenous Candida krusei infection in neutropenic mice. J Infect Dis (1993) 1.19
Prospective evaluation of effects of broad-spectrum antibiotics on gastrointestinal yeast colonization of humans. Antimicrob Agents Chemother (1993) 1.18
Molecular characterization of the OXA-7 beta-lactamase gene. Antimicrob Agents Chemother (1995) 1.16
Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: a matched cohort study. Am J Med (1996) 1.14
Rationale for combination antifungal therapy. Pharmacotherapy (2001) 1.14
Overexpression of Sbe2p, a Golgi protein, results in resistance to caspofungin in Saccharomyces cerevisiae. Antimicrob Agents Chemother (2002) 1.14
Prospective study of the impact of broad-spectrum antibiotics on the yeast flora of the human gut. Eur J Clin Microbiol Infect Dis (1994) 1.13
Utility of early versus late fiberoptic bronchoscopy in the evaluation of new pulmonary infiltrates following hematopoietic stem cell transplantation. Bone Marrow Transplant (2009) 1.13
Effectiveness and nephrotoxicity of intravenous colistin for treatment of patients with infections due to polymyxin-only-susceptible (POS) gram-negative bacteria. Eur J Clin Microbiol Infect Dis (2006) 1.13
Safety, plasma concentrations, and efficacy of high-dose fluconazole in invasive mold infections. J Infect Dis (1995) 1.12
Surgical wound infection caused by Rahnella aquatilis. J Clin Microbiol (1994) 1.11
Urocortin in human gastric mucosa: relationship to inflammatory activity. J Clin Endocrinol Metab (2003) 1.10
Triplet combination with irinotecan plus oxaliplatin plus continuous-infusion fluorouracil and leucovorin as first-line treatment in metastatic colorectal cancer: a multicenter phase II trial. J Clin Oncol (2002) 1.09
Typing of sandflies from Greece and Cyprus by DNA polymorphism of 18S rRNA gene. Insect Mol Biol (1999) 1.09
Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease. Am J Gastroenterol (2001) 1.08
Update on antifungal drug resistance mechanisms of Aspergillus fumigatus. Drug Resist Updat (2006) 1.08
Ticks, tick-borne rickettsiae, and Coxiella burnetii in the Greek Island of Cephalonia. Ann N Y Acad Sci (2006) 1.07
A 5-year study of the bacterial pathogens associated with acute diarrhoea on the island of Crete, Greece, and their resistance to antibiotics. Eur J Epidemiol (2003) 1.07
Risk factors for the development of invasive fungal infections in allogeneic blood and marrow transplant recipients. Transpl Infect Dis (2002) 1.06
Kala-azar in Athens basin. Lancet (1994) 1.06
Aspergillus nidulans is frequently resistant to amphotericin B. Mycoses (2002) 1.05
Carriage of Rickettsia spp., Coxiella burnetii and Anaplasma spp. by endemic and migratory wild birds and their ectoparasites in Cyprus. Clin Microbiol Infect (2009) 1.04
Rickettsia conorii in Greece: comparison of a microimmunofluorescence assay and western blotting for seroepidemiology. Am J Trop Med Hyg (1993) 1.04
Changing pattern of cytokeratin 7 and 20 expression from normal epithelium to intestinal metaplasia of the gastric mucosa and gastroesophageal junction. Histol Histopathol (2002) 1.03
Brachyspira (Serpulina) pilosicoli spirochetemia in an immunocompromised patient. Infection (2002) 1.02
Mycobacterium tuberculosis at a comprehensive cancer centre: active disease in patients with underlying malignancy during 1990-2000. Clin Microbiol Infect (2004) 1.02
Infections in patients with chronic lymphocytic leukemia treated with fludarabine. Ann Intern Med (1998) 1.00
Epidemiological study of brucellosis in eight Greek villages using a computerised mapping programme. Eur J Epidemiol (1999) 0.99
Faunistic study of sandflies in Greece. Med Vet Entomol (2007) 0.99
The inflammatory bowel disease questionnaire: a review of its national validation studies. Inflamm Bowel Dis (2004) 0.98
An outbreak of diarrhoeal disease attributed to Shigella sonnei. Epidemiol Infect (1994) 0.98
Systemic mycoses in the immunocompromised host: an update in antifungal therapy. J Hosp Infect (2003) 0.98
Detection of ciprofloxacin resistance mutations in Campylobacter jejuni gyrA by nonradioisotopic single-strand conformation polymorphism and direct DNA sequencing. J Clin Lab Anal (1996) 0.98
The impact of norfloxacin, ciprofloxacin and ofloxacin on human gut colonization by Candida albicans. Scand J Infect Dis (2001) 0.98
Candidemia in immunocompromised and immunocompetent critically ill patients: a prospective comparative study. Eur J Clin Microbiol Infect Dis (2007) 0.97
Q fever in the Greek island of Crete: detection, isolation, and molecular identification of eight strains of Coxiella burnetii from clinical samples. J Clin Microbiol (1998) 0.97
Gram-negative bacteremia in non-neutropenic patients: a 3-year review. Infection (1998) 0.97
Appendectomy, tonsillectomy, and risk of inflammatory bowel disease: case-controlled study in Crete. Dis Colon Rectum (1999) 0.96
In vitro susceptibility of Citrobacter species to various antimicrobial agents. Antimicrob Agents Chemother (1987) 0.96
Effects of broad-spectrum antibiotics on colonization of gastrointestinal tracts of mice by Candida albicans. Antimicrob Agents Chemother (1994) 0.95
Resistance of Mycobacterium tuberculosis isolates in different populations in Greece during 1993-2002. Int J Tuberc Lung Dis (2006) 0.95
Salvage chemotherapy in anthracycline-pretreated metastatic breast cancer patients with docetaxel and gemcitabine: a multicenter phase II trial. Greek Breast Cancer Cooperative Group. Ann Oncol (1999) 0.95
Ulcerative colitis: no rise in mortality in a European-wide population based cohort 10 years after diagnosis. Gut (2006) 0.95
Resistance status and evolution trends of Klebsiella pneumoniae isolates in a university hospital in Greece: ineffectiveness of carbapenems and increasing resistance to colistin. Chemotherapy (2010) 0.94
Canine visceral leishmaniasis: successful chemotherapy induces macrophage antileishmanial activity via the L-arginine nitric oxide pathway. Antimicrob Agents Chemother (1996) 0.93
The calcineurin pathway inhibitor tacrolimus enhances the in vitro activity of azoles against Mucorales via apoptosis. Eukaryot Cell (2013) 0.93
Sources and outcome of bloodstream infections in cancer patients: the role of central venous catheters. Eur J Clin Microbiol Infect Dis (2007) 0.93
Phylogenetic relationships of phlebotomine sandflies inferred from small subunit nuclear ribosomal DNA. Insect Mol Biol (2000) 0.92
Infections in traumatic brain injury patients. Clin Microbiol Infect (2011) 0.91
Candidaemia: incidence, risk factors, characteristics and outcomes in immunocompetent critically ill patients. Clin Microbiol Infect (2009) 0.91
Influence of type of cancer and hematopoietic stem cell transplantation on clinical presentation of Pneumocystis jiroveci pneumonia in cancer patients. Eur J Clin Microbiol Infect Dis (2006) 0.91
Anti-cardiolipin and anti-beta2-glycoprotein I antibodies in patients with inflammatory bowel disease. Dig Dis Sci (1998) 0.90
Association between H1N1 infection severity and obesity-adiponectin as a potential etiologic factor. J Infect Dis (2010) 0.90
Ulcerative colitis is as common in Crete as in northern Europe: a 5-year prospective study. Eur J Gastroenterol Hepatol (1996) 0.90
Airborne hydrogen peroxide for disinfection of the hospital environment and infection control: a systematic review. J Hosp Infect (2011) 0.90
A case of Opisthorchis felineus infestation in a pilot from Greece. Infection (2003) 0.90
Molecular epidemiology and risk factors for colonization by vancomycin-resistant Enterococcus in patients with hematologic malignancies. Infect Control Hosp Epidemiol (2011) 0.90